Skip to content

Nhân Chứng Giê-hô-va

Chọn ngôn ngữ Việt

Khoa ung thư

Xử lý thiếu máu

Thuốc kích thích tạo hồng cầu

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines.

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Nguồn‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Mã bài‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institution.

Azzarà A, Carulli G, Galimberti S, Baratè C, Fazzi R, Cervetti G, Petrini M.

Nguồn‎: Am J Hematol 2011;86(9):762-7.

Mã bài‎: PubMed 21850658

DOI‎: 10.1002/ajh.22111

https://www.ncbi.nlm.nih.gov/pubmed/21850658

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma.

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.

Nguồn‎: Acta Haematol 2007;117(3):162-7.

Mã bài‎: PubMed 17148935

DOI‎: 10.1159/000097464

https://www.ncbi.nlm.nih.gov/pubmed/17148935

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

Nguồn‎: Am J Hematol 2013;88(12):990-6.

Mã bài‎: PubMed 23873823

DOI‎: 10.1002/ajh.23552

https://www.ncbi.nlm.nih.gov/pubmed/23873823

Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study.

Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Würschmidt F, Petry KU, Kimmig R, Elling D, Thomssen C, von Minckwitz G, Möbus V, Hinke A, Kümmel S, Budach V, Lichtenegger W, Schmid P.

Nguồn‎: J Clin Oncol 2011;29(28):3791-7.

Mã bài‎: PubMed 21860000

DOI‎: 10.1200/JCO.2010.30.4899

https://www.ncbi.nlm.nih.gov/pubmed/21860000

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial.

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Nguồn‎: Cancer 2012;118(3):848-55.

Mã bài‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205

Management of anemia in cancer patients.

Calabrich A, Katz A.

Nguồn‎: Future Oncol 2011;7(4):507-17.

Mã bài‎: PubMed 21463140

DOI‎: 10.2217/fon.11.24

https://www.ncbi.nlm.nih.gov/pubmed/21463140

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.

Deger M, Eisterer W, Kutikova L, Salek S.

Nguồn‎: Support Care Cancer 2013;21(2):485-93.

Mã bài‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Nguồn‎: BJU Int 2011;108(10):1582-7.

Mã bài‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Nguồn‎: J Clin Oncol 2010;28(13):2239-45.

Mã bài‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses.

Ford PA, Grant SJ, Mick R, Keck G.

Nguồn‎: J Clin Oncol 2015;33(15):1674-9.

Mã bài‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

Nguồn‎: Br J Cancer 2011;105(9):1267-72.

Mã bài‎: PubMed 21959870

DOI‎: 10.1038/bjc.2011.395

https://www.ncbi.nlm.nih.gov/pubmed/21959870

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

Nguồn‎: J Intern Med 2017;281(3):284-99.

Mã bài‎: PubMed 27926979

DOI‎: 10.1111/joim.12579

https://www.ncbi.nlm.nih.gov/pubmed/27926979

Update on safety of ESAs in cancer-induced anemia.

Glaspy J.

Nguồn‎: J Natl Compr Canc Netw 2012;10(5):659-66.

Mã bài‎: PubMed 22570294

https://www.ncbi.nlm.nih.gov/pubmed/22570294

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes.

Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K.

Nguồn‎: Int J Hematol 2015;102(4):401-12.

Mã bài‎: PubMed 26323997

DOI‎: 10.1007/s12185-015-1862-5

https://www.ncbi.nlm.nih.gov/pubmed/26323997

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Nguồn‎: Cancer 2013;119(1):107-14.

Mã bài‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A, Thomssen C, Kurbacher C, Kuhn W, Nitz U, Runnebaum IB, Hinke A, Kreienberg R, Untch M; on behalf of the AGO Breast Study Group.

Nguồn‎: J Natl Cancer Inst 2013;105(14):1018-26.

Mã bài‎: PubMed 23860204

DOI‎: 10.1093/jnci/djt145

https://www.ncbi.nlm.nih.gov/pubmed/23860204

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials.

Ohashi Y, Uemura Y, Fujisaka Y, Sugiyama T, Ohmatsu H, Katsumata N, Okamoto R, Saijo N, Hotta T.

Nguồn‎: Cancer Sci 2013;104(4):481-5.

Mã bài‎: PubMed 23331490

DOI‎: 10.1111/cas.12105

https://www.ncbi.nlm.nih.gov/pubmed/23331490

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Nguồn‎: Support Care Cancer 2012;20(1):159-65.

Mã bài‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial.

Pronzato P, Cortesi E, van der Rijt CC, Bols A, Moreno-Nogueira JA, de Oliveira CF, Barrett-Lee P, Ostler PJ, Rosso R; for the EPO-INT-47 Study Group.

Nguồn‎: Oncologist 2010;15(9):935-43.

Mã bài‎: PubMed 20798194

DOI‎: 10.1634/theoncologist.2009-0279

https://www.ncbi.nlm.nih.gov/pubmed/20798194

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Nguồn‎: Lung Cancer 2012;76(3):478-85.

Mã bài‎: PubMed 22277104

DOI‎: 10.1016/j.lungcan.2011.12.015

https://www.ncbi.nlm.nih.gov/pubmed/22277104

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.

Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G.

Nguồn‎: Eur J Haematol 2016;97(1):33-8.

Mã bài‎: PubMed 26341961

DOI‎: 10.1111/ejh.12679

https://www.ncbi.nlm.nih.gov/pubmed/26341961

Sắt tiêm tĩnh mạch

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines.

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Nguồn‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Mã bài‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514

Intravenous iron in oncology.

Auerbach M, Ballard H.

Nguồn‎: J Natl Compr Canc Netw 2008;6(6):585-92.

Mã bài‎: PubMed 18597712

https://www.ncbi.nlm.nih.gov/pubmed/18597712

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.

Calleja JL, Delgado S, Del Val A, Hervás A, Larraona JL, Terán Á, Cucala M, Mearin F; Colon Cancer Study Group.

Nguồn‎: Int J Colorectal Dis 2016;31(3):543-51.

Mã bài‎: PubMed 26694926

DOI‎: 10.1007/s00384-015-2461-x

https://www.ncbi.nlm.nih.gov/pubmed/26694926

Total dose iron dextran infusion in cancer patients: is it SaFe2+?

Gilreath JA, Stenehjem DD, Rodgers GM.

Nguồn‎: J Natl Compr Canc Netw 2012;10(5):669-76.

Mã bài‎: PubMed 22570295

https://www.ncbi.nlm.nih.gov/pubmed/22570295

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Nguồn‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Mã bài‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108

Perioperative anemia management in colorectal cancer patients: a pragmatic approach.

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M.

Nguồn‎: World J Gastroenterol 2014;20(8):1972-85.

Mã bài‎: PubMed 24587673

DOI‎: 10.3748/wjg.v20.i8.1972

https://www.ncbi.nlm.nih.gov/pubmed/24587673

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Nguồn‎: J Clin Oncol 2008;26(10):1619-25.

Mã bài‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials.

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

Nguồn‎: J Cancer Res Clin Oncol 2012;138(2):179-87.

Mã bài‎: PubMed 21972052

DOI‎: 10.1007/s00432-011-1072-3

https://www.ncbi.nlm.nih.gov/pubmed/21972052

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia.

Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.

Nguồn‎: Ann Oncol 2013;24(2):475-82.

Mã bài‎: PubMed 23071262

DOI‎: 10.1093/annonc/mds338

https://www.ncbi.nlm.nih.gov/pubmed/23071262


Phần y khoa của trang web jw.org được thiết kế nhằm cung cấp tài liệu chủ yếu cho bác sĩ và những người thuộc ngành y. Phần này không tư vấn về y khoa hoặc đề nghị bất cứ phương pháp điều trị nào, và cũng không thay thế cho bác sĩ. Tài liệu y khoa được liệt kê trong phần này không do Nhân Chứng Giê-hô-va xuất bản, nhưng bàn về những phương pháp điều trị không truyền máu mà bác sĩ có thể quyết định xem xét. Chính bác sĩ có trách nhiệm phân loại những thông tin cập nhật hơn, bàn bạc các phương cách điều trị và hỗ trợ bệnh nhân lựa chọn một cách sáng suốt dựa trên tình trạng sức khỏe, ước nguyện và niềm tin của bệnh nhân. Không phải tất cả các phương pháp được liệt kê đều thích hợp cho mọi bệnh nhân.

Đôi lời với bệnh nhân: Xin luôn hỏi ý kiến của bác sĩ về vấn đề sức khỏe và cách điều trị. Cần đi khám bác sĩ nếu cảm thấy bệnh.

Việc sử dụng trang web này được chi phối bởi các điều khoản sử dụng.